AmpliChip: Difference between revisions
Content deleted Content added
m →top: cleanup & AWB Task (changing Swiss links) |
m Normalize {{Multiple issues}}: Remove {{Multiple issues}} for only 1 maintenance template(s): More citations needed |
||
| Line 1: | Line 1: | ||
{{Multiple issues| |
|||
{{more citations needed|date=July 2018}} |
{{more citations needed|date=July 2018}} |
||
{{Orphan|date=November 2014}} |
{{Orphan|date=November 2014}} |
||
}} |
|||
'''AmpliChip''' is a family of clinical tests from the [[Switzerland|Swiss]] healthcare company [[Hoffmann-La Roche]] which aim to find out the patients' genotype using micro-array technology. The tests include the [[AmpliChip CYP450 Test|CYP450 Test]] and the [[AmpliChip P53 Test|P53 Test]]. The CYP450 Test was approved by the U.S. [[Food and Drug Administration]].<ref>{{Cite news|url=https://www.asianscientist.com/2012/02/tech/china-approves-microarray-platform-affymetrix-gene-chip-system-2012/|title=China Approves First Microarray Platform For In Vitro Diagnostic Use|date=2012-02-16|work=Asian Scientist Magazine {{!}} Science, technology and medical news updates from Asia|access-date=2018-07-25|language=en-US}}</ref> |
'''AmpliChip''' is a family of clinical tests from the [[Switzerland|Swiss]] healthcare company [[Hoffmann-La Roche]] which aim to find out the patients' genotype using micro-array technology. The tests include the [[AmpliChip CYP450 Test|CYP450 Test]] and the [[AmpliChip P53 Test|P53 Test]]. The CYP450 Test was approved by the U.S. [[Food and Drug Administration]].<ref>{{Cite news|url=https://www.asianscientist.com/2012/02/tech/china-approves-microarray-platform-affymetrix-gene-chip-system-2012/|title=China Approves First Microarray Platform For In Vitro Diagnostic Use|date=2012-02-16|work=Asian Scientist Magazine {{!}} Science, technology and medical news updates from Asia|access-date=2018-07-25|language=en-US}}</ref> |
||
Revision as of 01:59, 31 May 2020
 | This article needs additional citations for verification. (July 2018) |
AmpliChip is a family of clinical tests from the Swiss healthcare company Hoffmann-La Roche which aim to find out the patients' genotype using micro-array technology. The tests include the CYP450 Test and the P53 Test. The CYP450 Test was approved by the U.S. Food and Drug Administration.[1]
References
- ^ "China Approves First Microarray Platform For In Vitro Diagnostic Use". Asian Scientist Magazine | Science, technology and medical news updates from Asia. 2012-02-16. Retrieved 2018-07-25.